Predictive value of sentinel lymph node biopsy prior to neoadjuvant chemotherapy in clinically node negative breast cancer.

被引：0
|
作者：
Jones, JL
Rhei, E
Gadd, MA
Howard-Mcnatt, M
Hughes, KS
Lesnikoski, BA
Christian, RL
Rabban, JT
Kaelin, C
Smith, BL
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
606
引用
收藏
页码：28S / 28S
页数：1
相关论文
共 50 条
  • [31] Sentinel lymph node biopsy for patients with breast cancer treated with neoadjuvant chemotherapy
    Shimazu, K.
    Tamaki, Y.
    Taguchi, T.
    Noguchi, S.
    BREAST, 2009, 18 : S62 - S62
  • [32] Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy
    Rebollo-Aguirre, A. C.
    Gallego-Peinado, M.
    Menjon-Beltran, S.
    Ramos-Font, C.
    Salamanca-Ballesteros, A.
    Pastor-Pons, E.
    Garcia-Garcia, J.
    Chamorro-Santos, C. E.
    Moreno-Caballero, M.
    Llamas-Elvira, J. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S324 - S324
  • [33] Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Clinically Node Negative Patients after Neoadjuvant Chemotherapy for Breast Cancer - A Systematic Review and Metaanalysis.
    Tan, V. K. M.
    Lee, S. Y.
    Goh, B. K. P.
    Chung, A.
    Sebastian, M. G.
    Yong, W. S.
    Wong, W. K.
    CANCER RESEARCH, 2009, 69 (24) : 541S - 541S
  • [34] The use of Tc-99 tilmanocept in sentinel lymph node biopsy after neoadjuvant chemotherapy in clinically node-negative patients with breast cancer
    Unkart, J. T.
    Wallace, A. M.
    CANCER RESEARCH, 2016, 76
  • [35] Is sentinel lymph node biopsy necessary in breast cancer patients who were diagnosed as initially clinically node-negative before neoadjuvant chemotherapy?
    Fujita, T.
    Sakuragi, M.
    Miyazaki, C.
    Siba, S.
    Tanaka, Y.
    Koike, R.
    Shiozawa, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Sentinel node biopsy prior to neoadjuvant chemotherapy
    Sabel, MS
    Schott, AF
    Pierce, LJ
    Kleer, CG
    Cimmino, VM
    Diehl, KM
    Merajver, S
    Hayes, DF
    Chang, AE
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S16 - S16
  • [37] Is sentinel lymph node biopsy necessary in breast cancer patients who were diagnosed as initially clinically node-negative before neoadjuvant chemotherapy?
    Fujita, T.
    Sakuragi, M.
    Miyazaki, C.
    Shiba, S.
    Tanaka, Y.
    Nishida, S.
    CANCER RESEARCH, 2019, 79 (04)
  • [38] Sentinel node biopsy prior to neoadjuvant chemotherapy
    Sabel, MS
    Schott, AF
    Kleer, CG
    Merajver, S
    Cimmino, VM
    Diehl, KM
    Hayes, DF
    Chang, AE
    Pierce, LJ
    AMERICAN JOURNAL OF SURGERY, 2003, 186 (02): : 102 - 105
  • [39] Predictive factors and value of ypN plus after neoadjuvant chemotherapy in clinically lymph node-negative breast cancer
    Fukada, I.
    Ito, Y.
    Kobayashi, K.
    Shibayama, T.
    Miyamoto, K.
    Takahashi, S.
    Horii, R.
    Akiyama, F.
    Iwase, T.
    Ohno, S.
    BREAST, 2017, 32 : S92 - S92
  • [40] Predictive Factors and Value of ypN plus after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer
    Fukada, Ippei
    Araki, Kazuhiro
    Kobayashi, Kokoro
    Shibayama, Tomoko
    Takahashi, Shunji
    Horii, Rie
    Akiyama, Futoshi
    Iwase, Takuji
    Ohno, Shinji
    Hatake, Kiyohiko
    Hozumi, Yasuo
    Sata, Naohiro
    Ito, Yoshinori
    PLOS ONE, 2016, 11 (09):
12345